Ignite Creation Date:
2025-12-24 @ 5:36 PM
Ignite Modification Date:
2026-01-02 @ 12:10 PM
Study NCT ID:
NCT04797468
Status:
WITHDRAWN
Last Update Posted:
2023-01-17
First Post:
2021-03-04
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase 1 Study of the CD73 Inhibitor(HLX23) Alone in Participants With Solid Tumor
Sponsor:
Shanghai Henlius Biotech
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Advanced Solid Tumor | View |
Keywords: